- Joined
- May 27, 2020
- Messages
- 31,902
MAPS’ Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD
The highly statistically significant results and excellent safety record suggest MDMA-assisted therapy will be approved as effective treatment for severe, chronic PTSD in 2023. 67% of participants who received three MDMA-assisted therapy sessions no longer qualified for a PTSD diagnosis and 88%...
maps.org
rejoice!
Let's give some applause to the amazing people at MAPS! This is a historic moment.